February 15, 2022 Comments Off on Drug Patent Expirations for the Week of February 13, 2022 Posted in: Uncategorized
KYNMOBI (apomorphine hydrochloride) Sunovion pharms inc Patent: 9,855,221 Expiration: Feb 14, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expir…
February 15, 2022 Comments Off on New patent expiration for King Pharms drug LEVOXYL Posted in: Uncategorized
Annual Drug Patent Expirations for LEVOXYL Levoxyl is a drug marketed by King Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for King Pharms drug LEVOXYL appeared first on D…
